434 related articles for article (PubMed ID: 32602848)
1. Exosome-transmitted long non-coding RNA
Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
Aging (Albany NY); 2020 Jun; 12(12):11550-11567. PubMed ID: 32602848
[TBL] [Abstract][Full Text] [Related]
2. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma.
Yao Z; Jia C; Tai Y; Liang H; Zhong Z; Xiong Z; Deng M; Zhang Q
Aging (Albany NY); 2020 Jun; 12(12):11843-11863. PubMed ID: 32554864
[TBL] [Abstract][Full Text] [Related]
3. Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression.
Chen W; Quan Y; Fan S; Wang H; Liang J; Huang L; Chen L; Liu Q; He P; Ye Y
Cancer Lett; 2020 Apr; 475():119-128. PubMed ID: 32014458
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA highly up-regulated in liver cancer promotes exosome secretion.
Cao SQ; Zheng H; Sun BC; Wang ZL; Liu T; Guo DH; Shen ZY
World J Gastroenterol; 2019 Sep; 25(35):5283-5299. PubMed ID: 31558873
[TBL] [Abstract][Full Text] [Related]
5. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z
Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
[TBL] [Abstract][Full Text] [Related]
7. RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma.
Huang X; Sun L; Wen S; Deng D; Wan F; He X; Tian L; Liang L; Wei C; Gao K; Fu Q; Li Y; Jiang J; Zhai R; He M
Cancer Sci; 2020 Sep; 111(9):3338-3349. PubMed ID: 32506598
[TBL] [Abstract][Full Text] [Related]
8. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.
Lee YR; Kim G; Tak WY; Jang SY; Kweon YO; Park JG; Lee HW; Han YS; Chun JM; Park SY; Hur K
Int J Cancer; 2019 Mar; 144(6):1444-1452. PubMed ID: 30338850
[TBL] [Abstract][Full Text] [Related]
9. Exosomal linc-FAM138B from cancer cells alleviates hepatocellular carcinoma progression via regulating miR-765.
Zhuo C; Yi T; Pu J; Cen X; Zhou Y; Feng S; Wei C; Chen P; Wang W; Bao C; Wang J; Tang Q
Aging (Albany NY); 2020 Dec; 12(24):26236-26247. PubMed ID: 33401249
[TBL] [Abstract][Full Text] [Related]
10. Serum exosomal miR-638 is a prognostic marker of HCC via downregulation of VE-cadherin and ZO-1 of endothelial cells.
Yokota Y; Noda T; Okumura Y; Kobayashi S; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Gotoh K; Takeda Y; Tanemura M; Murakami T; Umeshita K; Doki Y; Eguchi H
Cancer Sci; 2021 Mar; 112(3):1275-1288. PubMed ID: 33426736
[TBL] [Abstract][Full Text] [Related]
11. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
12. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
13. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
[TBL] [Abstract][Full Text] [Related]
14. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
[TBL] [Abstract][Full Text] [Related]
16. Exosome-Mediated MiR-155 Transfer Contributes to Hepatocellular Carcinoma Cell Proliferation by Targeting PTEN.
Sun JF; Zhang D; Gao CJ; Zhang YW; Dai QS
Med Sci Monit Basic Res; 2019 Oct; 25():218-228. PubMed ID: 31645540
[TBL] [Abstract][Full Text] [Related]
17. Exosomes secreted by M2 macrophages promote cancer stemness of hepatocellular carcinoma via the miR-27a-3p/TXNIP pathways.
Li W; Xin X; Li X; Geng J; Sun Y
Int Immunopharmacol; 2021 Dec; 101(Pt A):107585. PubMed ID: 34601333
[TBL] [Abstract][Full Text] [Related]
18. Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma.
Zhang PF; Gao C; Huang XY; Lu JC; Guo XJ; Shi GM; Cai JB; Ke AW
Mol Cancer; 2020 Jun; 19(1):110. PubMed ID: 32593303
[TBL] [Abstract][Full Text] [Related]
19. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
[TBL] [Abstract][Full Text] [Related]
20. LncRNA THEMIS2-211, a tumor-originated circulating exosomal biomarker, promotes the growth and metastasis of hepatocellular carcinoma by functioning as a competing endogenous RNA.
Yao J; Hua X; Shi J; Hu X; Lui K; He K; Mai J; Lan T; Lu M
FASEB J; 2022 Apr; 36(4):e22238. PubMed ID: 35224785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
